Ascendis Pharma A/S
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ascendis Pharma A/S's past years’ income statements indicate that its last revenue has increased compared to the previous period by 421% to $266,718,000. The net income raised on -$481,447,000 and profit margin reached -181%. Total operating expenses were $677,864,000.
Profit Margin
| 2014 | 13.98M | -9.65M | -69.07% |
|---|---|---|---|
| 2015 | 8.11M | -32.92M | -405.54% |
| 2016 | 4.60M | -68.50M | -1487.3% |
| 2017 | 1.53M | -123.89M | -8097.84% |
| 2018 | 10.58M | -130.09M | -1229.53% |
| 2019 | 13.37M | -218.01M | -1630.03% |
| 2020 | 6.95M | -418.95M | -6025.53% |
| 2021 | 7.77M | -383.57M | -4931.56% |
| 2022 | 51.17M | -583.19M | -1139.63% |
| 2023 | 266.71M | -481.44M | -180.51% |
ASND Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 266.71M | 51.17M | 7.77M | 6.95M | 13.37M | 10.58M | 1.53M | 4.60M | 8.11M | 13.98M |
Cost of revenue | 44.39M | 12.13M | 3.52M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 222.32M | 39.03M | 4.25M | 6.95M | 13.37M | 10.58M | 1.53M | 4.60M | 8.11M | 13.98M |
Operating exp. | ||||||||||
Research and development | 413.45M | 379.62M | 295.86M | 260.90M | 191.62M | 140.28M | 99.58M | 66.02M | 40.52M | 19.69M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 677.86M | 600.85M | 456.04M | 337.57M | 240.09M | 165.33M | 113.07M | 77.52M | 49.94M | 25.97M |
Operating income | -455.54M | -561.81M | -451.79M | -330.62M | -226.71M | -154.75M | -111.54M | -72.92M | -41.82M | -11.98M |
Other income (expenses), net | -18.60M | -16.00M | 67.84M | -88.55M | 8.46M | 20.37M | -12.83M | 4.07M | 8.25M | 1.64M |
Income before tax | -474.14M | -577.81M | -383.94M | -419.17M | -218.25M | -130.49M | -124.37M | -68.73M | -33.57M | -10.34M |
Income tax expense | 7.30M | 5.37M | -367K | -219K | -234K | -394K | -477K | -227K | -652K | -682K |
Net income | -481.44M | -583.19M | -383.57M | -418.95M | -218.01M | -130.09M | -123.89M | -68.50M | -32.92M | -9.65M |
Earnings per share | ||||||||||
Basic EPS | -8.55 | -10.4 | -7 | -8.28 | -4.69 | -3.17 | -3.68 | -2.58 | -1.39 | -0.57 |
Diluted EPS | -8.55 | -10.4 | -7 | -8.28 | -4.69 | -3.17 | -3.68 | -2.58 | -1.39 | -0.57 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |